We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use ÌìÃÀÓ°Ôº, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Reporting against VMD published standards up to 31 March 2025.
Reporting against VMD published standards up to 31 March 2026.
Apply for authorisation of premises for the retail supply of POM-VPS and NFA-VPS veterinary medicines by suitably qualified persons (SQPs).
Increased discussion of suspected adverse events in social media following use of Arthramid Vet in horses.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Change to the information provided on adverse events in the Summary of Product Characteristics for Propalin Syrup, 40 mg/ml Dogs.
Residues of veterinary medicines in food 2025 surveillance results, a rolling summary.
Requirements for stock inventories which must be performed regularly.
Notification to the VMD if they have a reason to suspect, or know of, a threat to the continued supply of a veterinary medicine.
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve ÌìÃÀÓ°Ôº, we’d like to know more about your visit today. .